The University of Chicago Header Logo

Connection

Richard Schilsky to Neuregulin-1

Back to Details
This is a "connection" page, showing publications Richard Schilsky has written about Neuregulin-1.
Richard Schilsky
Connection Strength
0.907
Neuregulin-1
  1. Afatinib in patients with solid tumors with neuregulin 1 (NRG1) fusions: a case series from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study. ESMO Open. 2025 May; 10(5):104545.
    View in: PubMed
    Score: 0.907
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.